<?xml version="1.0" encoding="UTF-8"?>
<p>Overall CFR of COVID‐19 are estimated to be approximately 1%‐2%, rising to more than 15% in patients aged 80 years and over.
 <xref rid="apt15779-bib-0036" ref-type="ref">
  <sup>36</sup>
 </xref> Current WHO data surmise that most cases of COVID‐19 have mild to moderate disease (80%) with 13.8% experiencing severe disease defined by the following signs and symptoms within 24‐48 hours: shortness of breath; tachypnoea &gt;30 breaths per minute; hypoxia &lt;93%; hypoxaemia with PaO
 <sub>2</sub>/FiO
 <sub>2</sub> ratio &lt; 300 and/or pulmonary infiltrates &gt;50% of the lung field.
 <xref rid="apt15779-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref> Critical infections occur in 6.1% and are exemplified by septic shock, respiratory failure and/or multiorgan failure.
 <xref rid="apt15779-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="apt15779-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref> Approximately one quarter of hospitalised patients require intensive care and 4.3% die.
 <xref rid="apt15779-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref> The primary reason for transfer to ICU is the development of organ dysfunction with ARDS being the main catalyst.
 <xref rid="apt15779-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>
</p>
